Get MotifBio Email Alerts
Subscribe
About Us
Motif Bio is a clinical-stage biopharmaceutical company focused on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant Gram-positive bacteria, including MRSA.
Recent News
- Motif Bio Presents New Iclaprim Data at ECCMID 2019 April 16, 2019
- Motif Bio Reports Fiscal Year 2018 Results April 15, 2019
- Motif Bio to Present Iclaprim Data at ECCMID 2019 April 4, 2019
Navigation
Contact Us
Motif Bio plc
201 Temple Chambers
3-7 Temple Avenue
London EC4Y 0DT
United Kingdom
Motif BioSciences Inc.
125 Park Avenue, 25th Floor
New York, NY 10017
United States
General: info@motifbio.com
Investors: ir@motifbio.com
© 2019 Motif Bio | Disclaimer & Terms of Use